SAVE UP TO $700 IF YOU BOOK BEFORE JULY 17 2021
- 00DAYS
- 00HRS
- 00MINS
- 00SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San DiegoKatie Ching, PhDResearch Investigator at Ligand Pharmaceuticals, Inc.
Profile
Dr. Ching is a Research Investigator at Ligand Pharmaceuticals in Emeryville, CA. She received her Ph.D in Biochemistry and Molecular Biology from Georgetown University, followed by post-doctoral studies at the National Institutes of Health in Bethesda, Maryland. At Ligand, she has been responsible for the evaluation and characterization of transgenic chickens used for the discovery of human antibodies. The original transgenic platform, OmniChickenTM, has been used for antibody discovery programs by pharmaceutical industry partners since 2016.
Agenda Sessions
OmniClic: Transgenic Chickens Producing Human Antibodies for Bispecifics
8:45amView SessionOmniClic: Transgenic Chickens Producing Human Antibodies for Bispecifics
On DemandView Session